|
Academic Year: | 2017/8 |
Owning Department/School: | Department of Pharmacy & Pharmacology |
Credits: | 6 [equivalent to 12 CATS credits] |
Notional Study Hours: | 120 |
Level: | Masters UG & PG (FHEQ level 7) |
Period: |
|
Assessment Summary: | CW 100% |
Assessment Detail: |
|
Supplementary Assessment: |
|
Requisites: | In taking this module you cannot take PA50338 |
Description: | Aims: To update underpinning knowledge of pharmacology, physiology and pharmaceutical knowledge in respiratory disease management and therapeutics. Learning Outcomes: On successful completion of this unit students will be able to: 1. Describe and analyse the role of the healthcare professional / pharmacist in prescribing, administration and monitoring of medication for patients with respiratory disease (knowledge and understanding). 2. Explain the disease and patient monitoring factors in this therapeutic area (knowledge and understanding, professional practical skill). 3. Critically evaluate the evidence base for the management of respiratory disease (intellectual skill). 4. Reflect on their own practice in supporting patients with this disease and identify areas for continuous improvement (personal transferable skill). 5. Apply the knowledge gained in this unit to design enhancements to patient facing services and the patient experience (professional practical skill; intellectual skill; knowledge and understanding) Skills: * Planning & organisation (Taught/Facilitated) * Study skills (Taught/Facilitated) * Handling information (Taught/Facilitated) * Written communication (Taught/Facilitated/Assessed) * Working with others (Taught/Facilitated) * Scientific & practical skills (Taught) * Improving learning & performance (Taught/Facilitated/Assessed) * Information & communication technology (ICT) (Taught/Facilitated) * Problem solving (Taught) Content: * The Basics * Drug Delivery to the Lungs * Asthma * Chronic Obstructive Pulmonary Disease (COPD) * Non-CF Bronchiectasis * Pleural Lung Conditions * Cystic Fibrosis & Bronchiectasis * Pulmonary Embolism * Pulmonary Hypertension. |
Programme availability: |
PA50199 is Optional on the following programmes:Department of Pharmacy & Pharmacology
|
Notes:
|